Burning Rock Biotech Ltd logo

Burning Rock Biotech Ltd

$ 3.04 -0.05 (-1.62%) 11:08 PM EST
P/E:
At Loss
P/B:
1.73
Market Cap:
$ 321.42M
Enterprise V:
$ 180.57M
Volume:
139.78K
Avg Vol (2M):
196.96K
Also Trade In:
Volume:
139.78K
Market Cap $:
321.42M
PE Ratio:
At Loss
Avg Vol (2-Month):
196.96K
Enterprise Value $:
180.57M
PB Ratio:
1.73

Business Description

Description
Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.
Name Current Vs Industry Vs History
Cash-To-Debt 16.42
Equity-to-Asset 0.75
Debt-to-Equity 0.05
Debt-to-EBITDA -0.06
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.29
Distress
Grey
Safe
Beneish M-Score -4.1
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 48.04
9-Day RSI 51.15
14-Day RSI 53.63
6-1 Month Momentum % -32.29
12-1 Month Momentum % -74.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.73
Quick Ratio 3.31
Cash Ratio 2.78
Days Inventory 257.87
Days Sales Outstanding 63.49
Days Payable 134.7

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -67.5